Nadofaragene firadenovec
Generic name: nadofaragene firadenovec [ NAD-oh-FAR-a-jeen-FYE-ra-DEN-oh-vek ]
Brand name: Adstiladrin
Dosage form: intravesical suspension (vncg)
Drug class: Miscellaneous antineoplastics
What is nadofaragene firadenovec?
Nadofaragene firadenovec is used in adults to treat a certain type of bladder cancer.
Nadofaragene firadenovec may also be used for purposes not listed in this medication guide.
Nadofaragene firadenovec side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Nadofaragene firadenovec may cause serious side effects. Call your doctor at once if you have:
-
blood in your urine; or
-
chest pressure or pain.
Common side effects of nadofaragene firadenovec may include:
-
abnormal lab results;
-
chills;
-
urinary discharge;
-
bladder spasm;
-
painful urination;
-
urgency to urinate; or
-
blood in your urine.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Enfortumab vedotin
Enfortumab vedotin systemic is used for bladder cancer, urothelial carcinoma
Mitomycin
Mitomycin systemic is used for anal cancer, bladder cancer, pancreatic cancer, stomach cancer ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Warnings
People with a weak immune system should not prepare, administer, receive, or come into contact with nadofaragene firadenovec.
Before taking this medicine
You should not use nadofaragene firadenovec if you are allergic to interferon alfa or to any component of nadofaragene firadenovec.
Tell your doctor if you have:
-
a weak immune system (caused by disease or by using certain medicine).
Nadofaragene firadenovec may harm an unborn baby if the mother or the father is using this medicine.
-
If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 6 months after your last dose.
-
If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.
-
Tell your doctor right away if a pregnancy occurs.
Ask a doctor if it is safe to breastfeed while using this medicine.
How is nadofaragene firadenovec given?
Follow all directions on your prescription label and read all medication guides or instruction sheets.
A healthcare provider will administer nadofaragene firadenovec into your bladder through a urinary catheter and leave the medicine in the bladder for 1 hour. During this time, you will need to move around every 15 minutes.
Follow these steps every time you urinate for the first 2 days after treatment:
-
Add about half a cup of bleach to the toilet bowl before you urinate.
-
After urinating, wait 15 minutes before flushing the toilet.
You may be given other medications to help prevent serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.
Waiting long for a cystectomy (a surgery for bladder cancer) when the usual treatment does not work could make the cancer become more serious. Talk to your doctor about your risk.
People with a weak immune system should not prepare, administer, receive, or come into contact with nadofaragene firadenovec.
Nadofaragene firadenovec dosing information
Usual Adult Dose for Bladder Cancer:
Usual dose: 75 mL at a concentration of 3 x 10(11) viral particles (vp)/mL instilled once every three months into the bladder via a urinary catheter
Comments:
-Administer an anticholinergic as a premedication prior to each instillation of this drug.
Use: For the treatment of adult patients with high-risk Bacillus Calmette Guérin (BCG)-unresponsive non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for nadofaragene firadenovec.
What happens if I overdose?
In a medical setting an overdose would be treated quickly.
What should I avoid while receiving nadofaragene firadenovec?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect nadofaragene firadenovec?
Other drugs may affect nadofaragene firadenovec, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
More about nadofaragene firadenovec
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 1.01.